Zydus Lifesciences posts strong Q3 FY25 results with 30% net profit surge
Zydus Lifesciences Limited has reported robust financial performance for the third quarter of fiscal year 2025, driven by strong revenue growth momentum, expansion in key ... Read More
Zydus Lifesciences chairman Pankaj Patel honoured with Padma Bhushan
In a proud moment for the Indian lifesciences industry, Pankaj R. Patel, Chairman of Zydus Lifesciences Limited, has been awarded the prestigious Padma Bhushan. Conferred ... Read More
Zydus Lifesciences gets FDA approval for Phase 2b ALS trial of Usnoflast
Zydus Lifesciences, a global leader in pharmaceutical innovation, has received approval from the United States Food and Drug Administration (USFDA) to commence Phase II(b) clinical ... Read More
Zydus Lifesciences bags FDA approval for Fludrocortisone Acetate Tablets, boosting U.S. market presence
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) to produce Fludrocortisone Acetate Tablets USP, 0.1 mg, according ... Read More
Zydus Lifesciences launches fight against prostate cancer with new FDA-approved drug enzalutamide
Zydus Lifesciences Limited has achieved a significant milestone in the pharmaceutical industry. The company recently received final approval from the United States Food and Drug ... Read More
Zydus and CSIR-CDRI launch collaborative research for new CKD-induced osteoporosis treatment
Zydus Lifesciences Ltd and CSIR-Central Drug Research Institute (CDRI) have joined forces to develop an innovative drug targeting osteoporosis induced by chronic kidney disease (CKD). ... Read More
Zydus Lifesciences wins FDA approval for Amantadine Capsules, secures 180-day exclusivity
Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has achieved a significant regulatory milestone by receiving final approval from the United States Food and ... Read More
Zydus Lifesciences to acquire 50% stake in Sterling Biotech from Perfect Day to expand into sustainable protein market
Zydus Lifesciences Limited, a major player in the global pharmaceutical industry, has entered a pivotal partnership by acquiring a 50% stake in Sterling Biotech Limited ... Read More
Game-changing MRI technology: Zynext Ventures bets big on Neuro42’s brain imaging
Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has made a significant investment in Neuro42 Inc., a US-based company specialising in advanced ... Read More
Zydus Lifesciences receives tentative FDA approval for Azilsartan Medoxomil Tablets
Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil ... Read More